Validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resection

Introduction: There remains a paucity of literature examining the decision algorithm for use of nasoseptal flap (NSF) after endoscopic endonasal approaches (EEA) to pituitary adenoma resection. In 2018, we published the first ever flap risk score (FRS) to predict the use of NSF. We present here a va...

Full description

Bibliographic Details
Main Authors: Arsalaan Salehani, Matthew Parr, Travis J. Atchley, Sasha Howell, Dagoberto Estevez-Ordonez, Nicholas M.B. Laskay, Kristen Riley
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:World Neurosurgery: X
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590139724000619
_version_ 1797281212298952704
author Arsalaan Salehani
Matthew Parr
Travis J. Atchley
Sasha Howell
Dagoberto Estevez-Ordonez
Nicholas M.B. Laskay
Kristen Riley
author_facet Arsalaan Salehani
Matthew Parr
Travis J. Atchley
Sasha Howell
Dagoberto Estevez-Ordonez
Nicholas M.B. Laskay
Kristen Riley
author_sort Arsalaan Salehani
collection DOAJ
description Introduction: There remains a paucity of literature examining the decision algorithm for use of nasoseptal flap (NSF) after endoscopic endonasal approaches (EEA) to pituitary adenoma resection. In 2018, we published the first ever flap risk score (FRS) to predict the use of NSF. We present here a validity study examining the FRS as applied to our center. Methods: A retrospective review was completed of consecutive patients undergoing EEA from January 2015 to March 2021. The sensitivity, specificity, and predictive value of the FRS were calculated. A multivariate logistic model was used to determine the relative weight imaging characteristics in predicting need for NSF. The relative weighting of the FRS was then re-optimized. Results: A total of 376 patients underwent EEA for pituitary adenoma resection, with 113 (30.1%) requiring NSF. The FRS had a sensitivity and specificity of 43.4% and 94.7%, respectively. Sphenoid sinus extension increased the odds of needing a NSF equivalent to 19 mm of tumor height, as opposed to 6 mm in the original 2018 cohort. The re-optimized model had sensitivity and specificity of 79.6% and 76.4%, respectively. Conclusion: We present a validity study examining the utility of FRS in predicting the use of NSF after EEA for pituitary adenoma resection. Our results show that while FRS is still predictive of the need for NSF after EEA, it is not as predictive now as it was for its original cohort. Therefore, a more comprehensive model is necessary to more accurately stratify patients’ preoperative risk for NSF.
first_indexed 2024-03-07T16:53:21Z
format Article
id doaj.art-baccd77ea8d348139cb1f0436a6d632b
institution Directory Open Access Journal
issn 2590-1397
language English
last_indexed 2024-03-07T16:53:21Z
publishDate 2024-04-01
publisher Elsevier
record_format Article
series World Neurosurgery: X
spelling doaj.art-baccd77ea8d348139cb1f0436a6d632b2024-03-03T04:30:08ZengElsevierWorld Neurosurgery: X2590-13972024-04-0122100330Validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resectionArsalaan Salehani0Matthew Parr1Travis J. Atchley2Sasha Howell3Dagoberto Estevez-Ordonez4Nicholas M.B. Laskay5Kristen Riley6Dept. of Neurological Surgery, University of Alabama at Birmingham, Birmingham, AL, USADept. of Neurological Surgery, University of Alabama at Birmingham, Birmingham, AL, USADept. of Neurological Surgery, University of Alabama at Birmingham, Birmingham, AL, USA; Corresponding author. Department of Neurosurgery University of Alabama at Birmingham 1060 Faculty Office Tower 1720 2nd Avenue South Birmingham, AL 35294, USA.Dept. of Neurological Surgery, University of Alabama at Birmingham, Birmingham, AL, USADept. of Neurological Surgery, University of Alabama at Birmingham, Birmingham, AL, USADept. of Neurological Surgery, University of Alabama at Birmingham, Birmingham, AL, USADept. of Neurological Surgery, University of Alabama at Birmingham, Birmingham, AL, USAIntroduction: There remains a paucity of literature examining the decision algorithm for use of nasoseptal flap (NSF) after endoscopic endonasal approaches (EEA) to pituitary adenoma resection. In 2018, we published the first ever flap risk score (FRS) to predict the use of NSF. We present here a validity study examining the FRS as applied to our center. Methods: A retrospective review was completed of consecutive patients undergoing EEA from January 2015 to March 2021. The sensitivity, specificity, and predictive value of the FRS were calculated. A multivariate logistic model was used to determine the relative weight imaging characteristics in predicting need for NSF. The relative weighting of the FRS was then re-optimized. Results: A total of 376 patients underwent EEA for pituitary adenoma resection, with 113 (30.1%) requiring NSF. The FRS had a sensitivity and specificity of 43.4% and 94.7%, respectively. Sphenoid sinus extension increased the odds of needing a NSF equivalent to 19 mm of tumor height, as opposed to 6 mm in the original 2018 cohort. The re-optimized model had sensitivity and specificity of 79.6% and 76.4%, respectively. Conclusion: We present a validity study examining the utility of FRS in predicting the use of NSF after EEA for pituitary adenoma resection. Our results show that while FRS is still predictive of the need for NSF after EEA, it is not as predictive now as it was for its original cohort. Therefore, a more comprehensive model is necessary to more accurately stratify patients’ preoperative risk for NSF.http://www.sciencedirect.com/science/article/pii/S2590139724000619Endoscopic endonasal surgeryTranssphenoidal surgeryPituitary adenomaNasoseptal flapValidity
spellingShingle Arsalaan Salehani
Matthew Parr
Travis J. Atchley
Sasha Howell
Dagoberto Estevez-Ordonez
Nicholas M.B. Laskay
Kristen Riley
Validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resection
World Neurosurgery: X
Endoscopic endonasal surgery
Transsphenoidal surgery
Pituitary adenoma
Nasoseptal flap
Validity
title Validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resection
title_full Validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resection
title_fullStr Validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resection
title_full_unstemmed Validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resection
title_short Validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resection
title_sort validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resection
topic Endoscopic endonasal surgery
Transsphenoidal surgery
Pituitary adenoma
Nasoseptal flap
Validity
url http://www.sciencedirect.com/science/article/pii/S2590139724000619
work_keys_str_mv AT arsalaansalehani validityoftheflapriskscoreinpredictingnasoseptalflapuseafterendoscopictranssphenoidalpituitarymassresection
AT matthewparr validityoftheflapriskscoreinpredictingnasoseptalflapuseafterendoscopictranssphenoidalpituitarymassresection
AT travisjatchley validityoftheflapriskscoreinpredictingnasoseptalflapuseafterendoscopictranssphenoidalpituitarymassresection
AT sashahowell validityoftheflapriskscoreinpredictingnasoseptalflapuseafterendoscopictranssphenoidalpituitarymassresection
AT dagobertoestevezordonez validityoftheflapriskscoreinpredictingnasoseptalflapuseafterendoscopictranssphenoidalpituitarymassresection
AT nicholasmblaskay validityoftheflapriskscoreinpredictingnasoseptalflapuseafterendoscopictranssphenoidalpituitarymassresection
AT kristenriley validityoftheflapriskscoreinpredictingnasoseptalflapuseafterendoscopictranssphenoidalpituitarymassresection